Cost-effectiveness analysis of telemonitoring versus usual care in patients with heart failure: The TEHAF-study

Journal of Telemedicine and Telecare

Volumn 19, Issue 5, 2013, Pages 242-248

  Boyne, Josiane J J ^a   Van Asselt, Antoinette D I ^a   Gorgels, Anton P M ^a   Steuten, Lotte M G ^b   De Weerd, Gerjan ^c   Kragten, Johannes ^c   Vrijhoef, Hubertus J M ^d,e  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

^c Orbis Medical and Care Concern ^*  (Netherlands)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e TILBURG UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HEALTH CARE COST; HEART FAILURE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; QUALITY ADJUSTED LIFE YEAR; TELEMEDICINE; UNITED KINGDOM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; FEMALE; GREAT BRITAIN; HEALTH CARE COSTS; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY-ADJUSTED LIFE YEARS; TELEMEDICINE;

EID: 84890157013     PISSN: 1357633X     EISSN: 17581109     Source Type: Journal    
DOI: 10.1177/1357633X13495478     Document Type: Article

References (29)

1. Hoes AW, Mosterd A, Rutten FH, Poos MJJC. Does the number of patients with heart failure increase or decrease? In: Volksgezondheid Toekomst Verkenning, Nationaal Kompas Volksgezondheid. Bilthoven: RIVM 2006 [Dutch]
2. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002;106:3068-72.
3. McMurray JJV, Stewart S. The burden of heart failure. Eur Heart J Suppl 2002;4(Suppl. D):50-8.
4. Zannad F, Agrinier N, Alla F. Heart failure burden and therapy. Europace 2009;11(Suppl. 5):1-9.
5. Berry C, Murdoch DR, McMurray JJ. Economics of chronic heart failure. Eur J Heart Fail 2001;3:283-91.
6. Cleland JG, Lewinter C, Goode KM. Telemonitoring for heart failure: the only feasible option for good universal care? Eur J Heart Fail 2009;11:227-8.
7. Seto E. Cost comparison between telemonitoring and usual care of heart failure: a systematic review. Telemed J E Health 2008;14:679-86.
8. Klersy C, De Silvestri A, Gabutti G, Regoli F, Auricchio A. A meta-analysis of remote monitoring of heart failure patients. J Am Coll Cardiol 2009;54:1683-94.
9. Steventon A, Bardsley M, Billings J, et al. Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial. BMJ 2012;344:e3874.
10. Augustin U, Henschke C. Does telemonitoring lead to health and economic benefits in patients with chronic heart failure? - a systematic review. Gesundheitswesen 2012;74:e114-21[German]
11. Mistry H. Systematic review of studies of the cost-effectiveness of telemedicine and telecare. Changes in the economic evidence over twenty years. J Telemed Telecare 2012;18:1-6.
12. Boyne JJ, Vrijhoef HJ, Crijns HJ, et al. Tailored telemonitoring in patients with heart failure: results of a multicentre randomized controlled trial. Eur J Heart Fail 2012;14:791-801.
13. Boyne JJ, Vrijhoef HJ, Wit Rd, Gorgels AP. Telemonitoring in patients with heart failure, the TEHAF study: study protocol of an ongoing prospective randomised trial. Int J Nurs Stud 2011;48:94-9.
14. EuroQol - a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990;16:199-208.
15. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997; 35: 1095-108.
16. College voor zorgverzekeringen. Pharmacotherapeutic Compass. See http://www.fk.cvz.nl/ (last checked 7 May 2013) [Dutch]
17. Hakkaart-van Roijen L, Tan SS, Bouwmans CA. Manual for cost research. Methods and standard costprices for economic evaluation in health care. Actualised version 2010. Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg Geactualiseerde versie 2010 [Dutch]
18. Centraal Bureau voor de Statistiek. Statline. See http://statline.cbs.nl (last checked 7 May 2013)
19. Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med 1991;10:585-98.
20. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997;6:327-40.
21. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. London: Chapman & Hall, 1993.
22. van Hout BA, Al MJ, Gordon GS, Rutten FF. Costs, effects and C/E-ratios alongside a clinical trial. Health Econ 1994;3:309-19.
23. Zinnige en duurzame. See http://rvz.net/uploads/docs/Advies_Zinnige_en_duurzame_zorg.pdf (last checked 7 May 2013) [Dutch]
24. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J 2012;33:1787-847.
25. Benatar D, Bondmass M, Ghitelman J, Avitall B. Outcomes of chronic heart failure. Arch Intern Med 2003;163:347-52.
26. Johnston B, Wheeler L, Deuser J, Sousa KH. Outcomes of the Kaiser Permanente Tele-Home Health Research Project. Arch Fam Med 2000;9:40-5.
27. Kruijff AF, Hoevenaars CE. Telemonitoring, applications and possibilities in the Dutch health care. Zoetermeer: HFM;1999 [Dutch]
28. Bradford WD, Kleit A, Krousel-Wood MA, Re RM. Comparing willingness to pay for telemedicine across a chronic heart failure and hypertension population. Telemed J E Health 2005;11:430-8.
29. Goossens ME, Rutten-van Mölken MP, Vlaeyen JW, van der Linden SM. The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol 2000;53:688-95